Chimerix, Inc. (CMRX)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 0.9529 |
| Open | 0.9500 |
| Bid | 0.9779 x 200 |
| Ask | 1.0200 x 400 |
| Day's range | 0.9400 - 1.0250 |
| 52-week range | 0.8800 - 1.5700 |
| Volume | |
| Avg. volume | 434,467 |
| Market cap | 89.63M |
| Beta (5Y monthly) | 1.10 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.9400 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Insider MonkeyChimerix, Inc. (NASDAQ:CMRX) Q1 2024 Earnings Call Transcript
Chimerix, Inc. (NASDAQ:CMRX) Q1 2024 Earnings Call Transcript May 1, 2024 Chimerix, Inc. misses on earnings expectations. Reported EPS is $-0.25 EPS, expectations were $-0.21. Chimerix, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and gentlemen, […]
- GuruFocus.com
Chimerix Inc (CMRX) Q1 2024 Earnings Call Transcript Highlights: Strategic Developments and ...
Insights into Chimerix Inc's financial health, strategic progress in clinical trials, and future plans from the latest earnings call.
© 2024 Yahoo. All rights reserved.